Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leijuan Gan
Observed name:
Lei-Juan Gan
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0000-0001-9747-6053
Observed ORCID:
0000-0001-9747-6053
OpenAlex ID:
A5088801685
The past, present and future of conversion therapy for liver cancer.
2021
·
Tianqiang Song
, Mengran Lang
, et al.
·
American Journal of Cancer Research
·
43
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma
2023
·
Leijuan Gan
, Mengran Lang
, et al.
·
Journal of Hepatocellular Carcinoma
·
29
PDF
Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study.
2023
·
Mengran Lang
, Leijuan Gan
, et al.
·
PubMed Central
·
15
PDF
Lenvatinib, sintilimab combined interventional treatment vs bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma
2024
·
Ru-Yu Han
, Lei-Juan Gan
, et al.
·
World Journal of Gastroenterology
·
13
Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study
2022
·
Leijuan Gan
, Shaohua Ren
, et al.
·
Journal of Hepatocellular Carcinoma
·
13
PDF
Conversion of initially unresectable hepatocellular carcinoma (HCC) with triple-combination therapy (lenvatinib, anti-PD-1 antibodies, and transarterial therapy): A retrospective analysis.
2022
·
Tianqiang Song
, Mengran Lang
, et al.
·
Journal of Clinical Oncology
·
13
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy
2024
·
Ruyu Han
, Leijuan Gan
, et al.
·
Journal of Hepatocellular Carcinoma
·
10
PDF
Ectopic hepatocellular carcinoma of the right adrenal gland: a case description
2023
·
Leijuan Gan
, Shaohua Ren
, et al.
·
Quantitative Imaging in Medicine and Surgery
·
4
PDF
Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study
2024
·
Ruyu Han
, Leijuan Gan
, et al.
·
Journal of Hepatocellular Carcinoma
·
1
Bevacizumab combined with atezolizumab or sintilimab as second-line treatment in patients with advanced hepatocellular carcinoma: A retrospective study.
2023
·
Leijuan Gan
, Huikai Li
, et al.
·
Journal of Clinical Oncology
·
1
Efficacy of combination therapy with lenvatinib, programmed cell death 1 inhibitors and transarterial therapy: a propensity score-matching cohort study
2022
·
Mengran Lang
, Leijuan Gan
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
11
Citation count:
142
H-index:
7
I10-index:
7
Year
Topic
Type